Tag: SanofiCE
Sanofi-CE approves Dupixent in a form of severe asthma in children aged 6 to 11
PARIS, April 7 (Reuters) – Sanofi and Regeneron announced on Thursday that the European Commission has extended marketing authorization for their treatment Dupixent to treat severe asthma with type 2…